Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zymeworks Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)
From Kirby McInerney LLP
Via Business Wire
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
 
Via Benzinga
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
From Zymeworks Inc.
Via GlobeNewswire
ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)
From Kirby McInerney LLP
Via GlobeNewswire
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care. 
Via InvestorPlace
ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price. 
Via InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value. 
Via InvestorPlace
Zymeworks - Analysts Project A Big Turnaround
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. 
Via Talk Markets
7 Small-Cap Stocks With Significant Upside Potential in 2024
Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on. 
Via InvestorPlace
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
From Zymeworks Inc.
Via GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer
Via Investor Brand Network
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
From Zymeworks Inc.
Via GlobeNewswire
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
Via InvestorPlace
3 Top Stocks to Buy This Winter for Sizzling Summer Gains
With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains. 
Via InvestorPlace
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
A Look Into Healthcare Sector Value Stocks
 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS